177 related articles for article (PubMed ID: 22521044)
1. Serum peptidome patterns of breast cancer based on magnetic bead separation and mass spectrometry analysis.
Fan NJ; Gao CF; Zhao G; Wang XL; Liu QY
Diagn Pathol; 2012 Apr; 7():45. PubMed ID: 22521044
[TBL] [Abstract][Full Text] [Related]
2. Serum peptidome patterns of colorectal cancer based on magnetic bead separation and MALDI-TOF mass spectrometry analysis.
Fan NJ; Gao CF; Wang XL; Zhao G; Liu QY; Zhang YY; Cheng BG
J Biomed Biotechnol; 2012; 2012():985020. PubMed ID: 23091368
[TBL] [Abstract][Full Text] [Related]
3. Comparative serum proteomic analysis of serum diagnosis proteins of colorectal cancer based on magnetic bead separation and maldi-tof mass spectrometry.
Deng BG; Yao JH; Liu QY; Feng XJ; Liu D; Zhao L; Tu B; Yang F
Asian Pac J Cancer Prev; 2013; 14(10):6069-75. PubMed ID: 24289627
[TBL] [Abstract][Full Text] [Related]
4. Identification alpha-2-HS-glycoprotein precursor and tubulin beta chain as serology diagnosis biomarker of colorectal cancer.
Fan NJ; Kang R; Ge XY; Li M; Liu Y; Chen HM; Gao CF
Diagn Pathol; 2014 Mar; 9():53. PubMed ID: 24618180
[TBL] [Abstract][Full Text] [Related]
5. Serum peptidome patterns of hepatocellular carcinoma based on magnetic bead separation and mass spectrometry analysis.
Li K; He WH; Fan NJ; Gao CF; Zhao G; Sun GB; Zheng GB
Turk J Gastroenterol; 2014 Dec; 25 Suppl 1():147-52. PubMed ID: 25910294
[TBL] [Abstract][Full Text] [Related]
6. Serum peptidome patterns of hepatocellular carcinoma based on magnetic bead separation and mass spectrometry analysis.
Ying X; Han SX; Wang JL; Zhou X; Jin GH; Jin L; Wang H; Wu L; Zhang J; Zhu Q
Diagn Pathol; 2013 Aug; 8():130. PubMed ID: 23915185
[TBL] [Abstract][Full Text] [Related]
7. Serum peptidome patterns for early screening of esophageal squamous cell carcinoma.
Fan NJ; Gao CF; Zhao G; Wang XL; Qiao L
Biotechnol Appl Biochem; 2012; 59(4):276-82. PubMed ID: 23586861
[TBL] [Abstract][Full Text] [Related]
8. Identification of novel serum peptides biomarkers for female breast cancer patients in Western China.
Yang J; Xiong X; Liu S; Zhu J; Luo M; Liu L; Zhao L; Qin Y; Song T; Huang C
Proteomics; 2016 Mar; 16(6):925-34. PubMed ID: 26705257
[TBL] [Abstract][Full Text] [Related]
9. Mass spectrometry-based serum proteome pattern analysis in molecular diagnostics of early stage breast cancer.
Pietrowska M; Marczak L; Polanska J; Behrendt K; Nowicka E; Walaszczyk A; Chmura A; Deja R; Stobiecki M; Polanski A; Tarnawski R; Widlak P
J Transl Med; 2009 Jul; 7():60. PubMed ID: 19594898
[TBL] [Abstract][Full Text] [Related]
10. Serum peptidome profiling revealed platelet factor 4 as a potential discriminating Peptide associated with pancreatic cancer.
Fiedler GM; Leichtle AB; Kase J; Baumann S; Ceglarek U; Felix K; Conrad T; Witzigmann H; Weimann A; Schütte C; Hauss J; Büchler M; Thiery J
Clin Cancer Res; 2009 Jun; 15(11):3812-9. PubMed ID: 19470732
[TBL] [Abstract][Full Text] [Related]
11. Identification of novel low molecular weight serum peptidome biomarkers for non-small cell lung cancer (NSCLC).
Yang J; Song YC; Song TS; Hu XY; Guo YM; Li ZF; Dang CX; Huang C
J Clin Lab Anal; 2012 May; 26(3):148-54. PubMed ID: 22628229
[TBL] [Abstract][Full Text] [Related]
12. Plasma Peptidome Pattern of Breast Cancer Using Magnetic Beads-Based Plasma Fractionation and MALDI-TOF MS: A Case Control Study in Egypt.
Zaki A; Ramadan RA; Moez P; Ghareeb H; Elkarmouty A
Asian Pac J Cancer Prev; 2019 Jan; 20(1):175-184. PubMed ID: 30678429
[TBL] [Abstract][Full Text] [Related]
13. Potential biomarkers for esophageal carcinoma detected by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
Liu LH; Shan BE; Tian ZQ; Sang MX; Ai J; Zhang ZF; Meng J; Zhu H; Wang SJ
Clin Chem Lab Med; 2010 Jun; 48(6):855-61. PubMed ID: 20345231
[TBL] [Abstract][Full Text] [Related]
14. Identification of serum biomarkers for lung cancer using magnetic bead-based SELDI-TOF-MS.
Song QB; Hu WG; Wang P; Yao Y; Zeng HZ
Acta Pharmacol Sin; 2011 Dec; 32(12):1537-42. PubMed ID: 22019958
[TBL] [Abstract][Full Text] [Related]
15. [Analyzing urinary proteome patterns of metabolic syndrome patients with early renal injury by magnet bead separation and matrix-assisted laser desorption ionization time-of-flight mass spectrometry].
Gao BX; Li MX; Liu XJ; Cai JF; Fan XH; Yang XL; Li XM; Li XW
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Oct; 33(5):511-6. PubMed ID: 22338134
[TBL] [Abstract][Full Text] [Related]
16. Standardized peptidome profiling of human urine by magnetic bead separation and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.
Fiedler GM; Baumann S; Leichtle A; Oltmann A; Kase J; Thiery J; Ceglarek U
Clin Chem; 2007 Mar; 53(3):421-8. PubMed ID: 17272489
[TBL] [Abstract][Full Text] [Related]
17. [Application of serum proteomic mass spectrum analysis in breast cancer].
Ying MG; Chen Q; Ye YB; Chen HJ; Chen X; Zheng HY; Wu F
Zhonghua Zhong Liu Za Zhi; 2010 Sep; 32(9):698-702. PubMed ID: 21122387
[TBL] [Abstract][Full Text] [Related]
18. Identification of potential serum proteomic biomarkers for clear cell renal cell carcinoma.
Yang J; Yang J; Gao Y; Zhao L; Liu L; Qin Y; Wang X; Song T; Huang C
PLoS One; 2014; 9(11):e111364. PubMed ID: 25368985
[TBL] [Abstract][Full Text] [Related]
19. Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer.
Li J; Zhang Z; Rosenzweig J; Wang YY; Chan DW
Clin Chem; 2002 Aug; 48(8):1296-304. PubMed ID: 12142387
[TBL] [Abstract][Full Text] [Related]
20. Serum peptidome profiling for identifying pathological patterns in patients with primary nephrotic syndrome.
Huang LT; Wen Q; Zhao MZ; Li ZB; Luo N; Wang YT; Dong XQ; Yu XQ
Chin Med J (Engl); 2012 Dec; 125(24):4418-23. PubMed ID: 23253712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
